• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

液相色谱-串联质谱法同时测定人血浆中福辛普利及其活性代谢产物福辛普利拉的方法开发与验证

Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma.

作者信息

Cui Shuangjin, Feng Fang, Ma Ming, Liu Han, Chen Yun

机构信息

Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 210009, China.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1;854(1-2):143-51. doi: 10.1016/j.jchromb.2007.04.019. Epub 2007 Apr 25.

DOI:10.1016/j.jchromb.2007.04.019
PMID:17482898
Abstract

A highly sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for simultaneous determination of the prodrug fosinopril and its major active metabolite fosinoprilat for pharmacokinetic studies in healthy subjects. In order to get the lower limit of quantification (LLOQ), especially for analysis of fosinopril, key points of the method have been investigated including chromatographic conditions and selection of LC-MS/MS conditions. The analytes were extracted from plasma samples by liquid-liquid extraction, separated on a reversed-phase C(8) column using gradient procedure, and detected by tandem mass spectrometry with a triple quadrupole ionization interface. The analytes and internal standard zaleplon were detected using positive electrospray ionization (ESI) in the SRM mode. The LLOQ of the method down to 0.1 ng mL(-1) for fosinopril and 1.0 ng mL(-1) for fosinoprilat were identifiable and reproducible. The standard calibration curves for both fosinopril and fosinoprilat were linear over the ranges of 0.1-15.0 and 1.0-700 ng mL(-1) in human plasma, respectively. The within- and between-batch precisions (relative standard deviation (RSD)%) and the accuracy were acceptable. The validated method was successfully applied to reveal the pharmacokinetic properties of fosinopril and fosinoprilat after oral administration.

摘要

建立了一种高灵敏度和高选择性的液相色谱-串联质谱(LC-MS/MS)方法,并进行了验证,用于同时测定前药福辛普利及其主要活性代谢物福辛普利拉,以用于健康受试者的药代动力学研究。为了获得定量下限(LLOQ),特别是对于福辛普利的分析,研究了该方法的关键点,包括色谱条件和LC-MS/MS条件的选择。通过液-液萃取从血浆样品中提取分析物,使用梯度程序在反相C(8)柱上进行分离,并通过带有三重四极杆电离接口的串联质谱进行检测。分析物和内标扎来普隆在SRM模式下使用正电喷雾电离(ESI)进行检测。该方法对福辛普利的LLOQ低至0.1 ng mL(-1),对福辛普利拉的LLOQ为1.0 ng mL(-1),可识别且可重现。福辛普利和福辛普利拉在人血浆中的标准校准曲线分别在0.1-15.0和1.0-700 ng mL(-1)范围内呈线性。批内和批间精密度(相对标准偏差(RSD)%)以及准确度均可接受。经过验证的方法成功应用于揭示口服给药后福辛普利和福辛普利拉的药代动力学特性。

相似文献

1
Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma.液相色谱-串联质谱法同时测定人血浆中福辛普利及其活性代谢产物福辛普利拉的方法开发与验证
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1;854(1-2):143-51. doi: 10.1016/j.jchromb.2007.04.019. Epub 2007 Apr 25.
2
Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation.采用自动化96孔固相萃取法进行样品制备,液相色谱/电喷雾串联质谱法定量测定人血清中福辛普利拉。
Rapid Commun Mass Spectrom. 2000;14(12):1023-8. doi: 10.1002/1097-0231(20000630)14:12<1023::AID-RCM983>3.0.CO;2-K.
3
Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.高效液相色谱-串联质谱法同时测定人血浆中依那普利和依那普利拉及其在药代动力学研究中的应用
J Pharm Biomed Anal. 2009 Jan 15;49(1):163-7. doi: 10.1016/j.jpba.2008.10.012. Epub 2008 Oct 22.
4
Simultaneous determination of enalapril and enalaprilat in human plasma by liquid chromatography-tandem mass spectrometry.液相色谱-串联质谱法同时测定人血浆中依那普利和依那普利拉
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):337-42. doi: 10.1016/j.jchromb.2004.09.031.
5
Rapid quantification of lisinopril in human plasma by liquid chromatography/tandem mass spectrometry.采用液相色谱/串联质谱法快速定量测定人血浆中的赖诺普利。
Biomed Chromatogr. 2007 Apr;21(4):415-21. doi: 10.1002/bmc.774.
6
Simultaneous determination of three bufadienolides in rat plasma after intravenous administration of bufadienolides extract by ultra performance liquid chromatography electrospray ionization tandem mass spectrometry.超高效液相色谱-电喷雾电离串联质谱法同时测定大鼠静脉注射蟾毒配基提取物后血浆中三种蟾毒配基的含量
Anal Chim Acta. 2008 Mar 10;610(2):224-31. doi: 10.1016/j.aca.2008.01.029. Epub 2008 Jan 18.
7
Simultaneous quantification of fosinopril and its active metabolite fosinoprilat in rat plasma by UFLC-MS/MS: Application of formic acid in the stabilization of an ester-containing drug.超快速液相色谱-串联质谱法同时测定大鼠血浆中福辛普利及其活性代谢产物福辛普利拉:甲酸在含酯类药物稳定性中的应用
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 May 15;990:141-9. doi: 10.1016/j.jchromb.2015.03.028. Epub 2015 Apr 3.
8
Rapid and simultaneous determination of nifedipine and dehydronifedipine in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical herb-drug interaction study.液相色谱-串联质谱法快速同时测定人血浆中的硝苯地平和脱氢硝苯地平:在临床药-药相互作用研究中的应用
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):534-44. doi: 10.1016/j.jchromb.2007.02.026. Epub 2007 Feb 21.
9
Determination of captopril in human plasma, using solid phase extraction and high-performance liquid chromatography, coupled to mass spectrometry: application to bioequivalence study.采用固相萃取和高效液相色谱-质谱联用技术测定人血浆中的卡托普利:在生物等效性研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 1;850(1-2):59-67. doi: 10.1016/j.jchromb.2006.11.007. Epub 2006 Dec 4.
10
Simultaneous determination of metformin and rosiglitazone in human plasma by liquid chromatography/tandem mass spectrometry with electrospray ionization: application to a pharmacokinetic study.液相色谱/电喷雾电离串联质谱法同时测定人血浆中的二甲双胍和罗格列酮:在药代动力学研究中的应用
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1;854(1-2):91-8. doi: 10.1016/j.jchromb.2007.04.002. Epub 2007 Apr 8.

引用本文的文献

1
CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.CES1基因变异影响血管紧张素转换酶抑制剂的活性。
Pharmacogenomics J. 2016 Jun;16(3):220-30. doi: 10.1038/tpj.2015.42. Epub 2015 Jun 16.